Your browser doesn't support javascript.
loading
Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma.
Burger, Michael C; Forster, Marie-Therese; Romanski, Annette; Straßheimer, Florian; Macas, Jadranka; Zeiner, Pia S; Steidl, Eike; Herkt, Stefanie; Weber, Katharina J; Schupp, Jonathan; Lun, Jennifer H; Strecker, Maja I; Wlotzka, Karolin; Cakmak, Pinar; Opitz, Corinna; George, Rosemol; Mildenberger, Iris C; Nowakowska, Paulina; Zhang, Congcong; Röder, Jasmin; Müller, Elvira; Ihrig, Kristina; Langen, Karl-Josef; Rieger, Michael A; Herrmann, Eva; Bonig, Halvard; Harter, Patrick N; Reiss, Yvonne; Hattingen, Elke; Rödel, Franz; Plate, Karl H; Tonn, Torsten; Senft, Christian; Steinbach, Joachim P; Wels, Winfried S.
Affiliation
  • Burger MC; Dr. Senckenberg Institute of Neurooncology, Goethe University Hospital, Frankfurt, Germany.
  • Forster MT; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt, Germany.
  • Romanski A; Department of Neurosurgery, Goethe University Hospital, Frankfurt, Germany.
  • Straßheimer F; Institute for Transfusion Medicine and Immunohematology, Goethe University, Frankfurt and Red Cross Blood Donation Service Baden-Württemberg-Hessen, Frankfurt, Germany.
  • Macas J; Dr. Senckenberg Institute of Neurooncology, Goethe University Hospital, Frankfurt, Germany.
  • Zeiner PS; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt, Germany.
  • Steidl E; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt, Germany.
  • Herkt S; Institute of Neurology (Edinger Institute), Goethe University Hospital, Frankfurt, Germany.
  • Weber KJ; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Frankfurt, Germany.
  • Schupp J; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Lun JH; Dr. Senckenberg Institute of Neurooncology, Goethe University Hospital, Frankfurt, Germany.
  • Strecker MI; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt, Germany.
  • Wlotzka K; Institute of Neuroradiology, Goethe University Hospital, Frankfurt, Germany.
  • Cakmak P; Institute for Transfusion Medicine and Immunohematology, Goethe University, Frankfurt and Red Cross Blood Donation Service Baden-Württemberg-Hessen, Frankfurt, Germany.
  • Opitz C; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt, Germany.
  • George R; Institute of Neurology (Edinger Institute), Goethe University Hospital, Frankfurt, Germany.
  • Mildenberger IC; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Frankfurt, Germany.
  • Nowakowska P; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Zhang C; University Cancer Center (UCT), Goethe University Hospital, Frankfurt, Germany.
  • Röder J; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt, Germany.
  • Müller E; Institute of Neurology (Edinger Institute), Goethe University Hospital, Frankfurt, Germany.
  • Ihrig K; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Frankfurt, Germany.
  • Langen KJ; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Rieger MA; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt, Germany.
  • Herrmann E; Institute of Neurology (Edinger Institute), Goethe University Hospital, Frankfurt, Germany.
  • Bonig H; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Frankfurt, Germany.
  • Harter PN; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Reiss Y; Dr. Senckenberg Institute of Neurooncology, Goethe University Hospital, Frankfurt, Germany.
  • Hattingen E; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt, Germany.
  • Rödel F; Dr. Senckenberg Institute of Neurooncology, Goethe University Hospital, Frankfurt, Germany.
  • Plate KH; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt, Germany.
  • Tonn T; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt, Germany.
  • Senft C; Institute of Neurology (Edinger Institute), Goethe University Hospital, Frankfurt, Germany.
  • Steinbach JP; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Frankfurt, Germany.
  • Wels WS; German Cancer Research Center (DKFZ), Heidelberg, Germany.
Neuro Oncol ; 25(11): 2058-2071, 2023 11 02.
Article in En | MEDLINE | ID: mdl-37148198
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Glioblastoma / Receptors, Chimeric Antigen Limits: Humans Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2023 Type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Glioblastoma / Receptors, Chimeric Antigen Limits: Humans Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2023 Type: Article Affiliation country: Germany